Compare Stocks

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDMO Avid Bioservices	$6.52 -2.8%	$7.06	$4.07 ▼ $19.97	$412.33M	1.63	1.28 million shs	707,733 shs
LCI Lannett		$1.54	$0.64 ▼ $3.72	$7.38M	0.95	92,067 shs	280,600 shs
OGI Organigram	$1.87 +2.2%	$2.10	$0.97 ▼ $2.91	$192.98M	1.09	1.38 million shs	1.24 million shs
OSMT Osmotica Pharmaceuticals		$1.16	$0.98 ▼ $4.95	$69.47M	2.34	396,682 shs	296,500 shs
TXMD TherapeuticsMD	$1.90 +0.5%	$2.27	$1.86 ▼ $4.73	$21.91M	1.03	21,529 shs	5,718 shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDMO Avid Bioservices	-2.83%	-5.51%	-7.12%	+5.16%	-66.75%
LCI Lannett	0.00%	0.00%	0.00%	0.00%	0.00%
OGI Organigram	+2.19%	-8.78%	-15.77%	+0.54%	-14.77%
OSMT Osmotica Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
TXMD TherapeuticsMD	+0.53%	-8.65%	-17.03%	-14.84%	-48.51%

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CDMO Avid Bioservices	3.7941 of 5 stars	3.4	3.0	0.0	4.5	2.6	1.7	0.0
LCI Lannett	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OGI Organigram	0.2189 of 5 stars	0.0	2.0	0.0	0.0	2.5	0.0	1.3
OSMT Osmotica Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TXMD TherapeuticsMD	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CDMO Avid Bioservices	2.75	Moderate Buy	$14.25	118.56% Upside
LCI Lannett	N/A	N/A	N/A	N/A
OGI Organigram	3.00	Buy	N/A	N/A
OSMT Osmotica Pharmaceuticals	N/A	N/A	N/A	N/A
TXMD TherapeuticsMD	2.00	Hold	N/A	N/A

Current Analyst Ratings

Latest LCI, TXMD, OGI, OSMT, and CDMO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/15/2024	OGI Organigram	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy
3/7/2024	CDMO Avid Bioservices	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$7.00

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CDMO Avid Bioservices	$149.27M	2.76	$0.14 per share	47.01	$3.03 per share	2.15
LCI Lannett	$340.58M	0.00	N/A	N/A	($23.34) per share	0.00
OGI Organigram	$120.01M	1.61	N/A	N/A	$2.48 per share	0.75
OSMT Osmotica Pharmaceuticals	$177.88M	0.00	N/A	1.00	$1.50 per share	0.00
TXMD TherapeuticsMD	$1.30M	16.85	N/A	N/A	$2.77 per share	0.69

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CDMO Avid Bioservices	$560K	-$0.17	N/A	∞	N/A	-8.12%	-5.18%	-2.16%	4/22/2024 (Estimated)
LCI Lannett	-$231.62M	-$18.88	N/A	N/A	N/A	-62.40%	N/A	-13.39%	N/A
OGI Organigram	-$184.34M	-$0.80	N/A	N/A	N/A	-173.48%	-30.94%	-27.70%	4/23/2024 (Estimated)
OSMT Osmotica Pharmaceuticals	-$79.59M	-$1.59	N/A	N/A	N/A	-138.76%	-81.23%	-20.97%	N/A
TXMD TherapeuticsMD	-$10.28M	N/A	0.00	∞	N/A	N/A	-25.54%	-14.87%	5/20/2024 (Estimated)

Latest LCI, TXMD, OGI, OSMT, and CDMO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/19/2024	N/A	CDMO Avid Bioservices	N/A	-$0.05	-$0.05	N/A	N/A	N/A
2/13/2024	Q1 2024	OGI Organigram	-$0.10	-$0.14	-$0.04	-$0.14	$28.61 million	$26.78 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CDMO Avid Bioservices	N/A	N/A	N/A	N/A	N/A
LCI Lannett	N/A	N/A	N/A	N/A	N/A
OGI Organigram	N/A	N/A	N/A	N/A	N/A
OSMT Osmotica Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
TXMD TherapeuticsMD	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CDMO Avid Bioservices	0.81	1.35	0.85
LCI Lannett	N/A	2.23	1.39
OGI Organigram	N/A	4.28	2.11
OSMT Osmotica Pharmaceuticals	N/A	0.43	0.42
TXMD TherapeuticsMD	N/A	1.72	1.72

Ownership

Institutional Ownership

Company	Institutional Ownership
CDMO Avid Bioservices	97.16%
LCI Lannett	40.28%
OGI Organigram	34.63%
OSMT Osmotica Pharmaceuticals	46.18%
TXMD TherapeuticsMD	30.74%

Insider Ownership

Company	Insider Ownership
CDMO Avid Bioservices	2.39%
LCI Lannett	13.12%
OGI Organigram	0.09%
OSMT Osmotica Pharmaceuticals	5.22%
TXMD TherapeuticsMD	1.20%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CDMO Avid Bioservices	365	63.24 million	61.73 million	Optionable
LCI Lannett	810	10.77 million	9.35 million	Optionable
OGI Organigram	984	103.20 million	103.11 million	Optionable
OSMT Osmotica Pharmaceuticals	302	62.59 million	59.32 million	Not Optionable
TXMD TherapeuticsMD	1	11.53 million	11.39 million	Optionable

LCI, TXMD, OGI, OSMT, and CDMO Headlines

Source	Headline
	TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com americanbankingnews.com - April 19 at 2:14 AM
	TherapeuticsMD gets grant for progesterone formulation for oral administration with reduced dosage pharmaceutical-technology.com - April 18 at 9:36 AM
	StockNews.com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD) americanbankingnews.com - April 13 at 2:18 AM
	TherapeuticsMD Announces Full Year 2023 Financial Results businesswire.com - March 29 at 4:00 PM
	TherapeuticsMD gets grant for progesterone formulations with reduced dosage for oral administration pharmaceutical-technology.com - March 28 at 11:17 AM
	25 Countries With Highest Abortion Rates msn.com - March 12 at 3:55 PM
	TherapeuticsMD, Inc. (TXMD) stock historical prices & data – Yahoo Finance sg.finance.yahoo.com - March 10 at 1:13 PM
	TherapeuticsMD Inc TXMD morningstar.com - December 29 at 5:48 PM
	Daily Markets: Today Brings Producer Prices, Retail Sales Data nasdaq.com - November 15 at 9:54 AM
	TherapeuticsMD to Consider Strategic Alternatives marketwatch.com - November 14 at 7:04 PM
	TherapeuticsMD exploring strategic alternatives for company msn.com - November 14 at 6:27 PM
	TherapeuticsMD Announces Third Quarter 2023 Financial Results finance.yahoo.com - November 14 at 6:27 PM
	Boca Raton-based prescription service announces layoffs, says a third of workforce could be cut bizjournals.com - October 4 at 5:11 PM
	TherapeuticsMD Inc. stock falls Wednesday, underperforms market marketwatch.com - September 20 at 6:46 PM
	TherapeuticsMD Inc. stock outperforms market despite losses on the day marketwatch.com - August 15 at 7:00 PM
	TherapeuticsMD Announces Second Quarter 2023 Financial Results finance.yahoo.com - August 14 at 7:50 AM
	Micron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of Directors finance.yahoo.com - August 9 at 8:38 PM
	TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors marketwatch.com - July 5 at 6:51 PM
	TherapeuticsMD Rejected by FDA, Delay Could Be Fatal thestreet.com - July 4 at 7:28 AM
	TherapeuticsMD Inc. [TXMD] Investment Appeal on the Rise knoxdaily.com - June 19 at 3:12 PM
	TherapeuticsMD: From Fallen And Forgotten To Cash Cow seekingalpha.com - May 23 at 9:28 AM
	TherapeuticsMD Announces First Quarter 2023 Financial Results finance.yahoo.com - May 15 at 4:19 PM
	NeuroBo Pharmaceuticals (NRBO) Appoints Mark A. Glickman to its ... - StreetInsider.com news.google.com - May 14 at 10:42 AM
	NeuroBo Pharmaceuticals Appoints Mark A. Glickman to its Board of ... - citybiz news.google.com - May 13 at 7:51 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024 1:50 PM
View Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
March 27, 2024 7:30 AM
View Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
3 Stocks About to Join the Rate Cut Party
March 21, 2024 7:12 AM
View 3 Stocks About to Join the Rate Cut Party
Prologis Stock Leading U.S. Logistics Boom
April 17, 2024 7:50 AM
View Prologis Stock Leading U.S. Logistics Boom
Buckle Up or Bail Out? The Self-Driving Taxi Market's Risky Ride
April 16, 2024 9:45 AM
View Buckle Up or Bail Out? The Self-Driving Taxi Market's Risky Ride

All Headlines

Company Descriptions

Avid Bioservices

NASDAQ:CDMO

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Lannett

NYSE:LCI

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Organigram

NASDAQ:OGI

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

Osmotica Pharmaceuticals

NASDAQ:OSMT

Osmotica Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, M-72, Arbaclofen ER, OS870, Divigel, OB Complete, Methylphenidate ER, Venlafaxine ER tablets (VERT), Hydromorphone ER, Sodium Benzoate/Sodium Phenylacetate, Oxybutynin ER, Prescription Prenatal Vitamins, Chlorzoxazone (Lorzone AG), Tramadol ER (ConZip AG), Nitrofurantoin and Osmodex ANDAs. The company was founded in 1986 and is headquartered in Bridgewater, NJ.

TherapeuticsMD

NASDAQ:TXMD

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial